The RESPImmun Faculty

	Eva BÖHM, PhD The role of JAK / STAT signaling in allergic asthma
Otto Loewi Research Centre, Division of Pharmacology, Medical University of Graz, Neue Stiftingtalstraße 6, A-8010 Graz; phone: +43-316-385 74103, fax: +43-316-385 79613, ✉ e-mail
websites: [RESPImmun]
• Profile     • Curriculum vitae     • PhD students     • Grants     • Publications ⏬

List of publications:

• See ⏩ Fodok Med Uni Graz

10 most significant publications:

1. Kasatkina LA, Heinemann A, Hudz YA, Thomas D, Böhm EM: Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation. Biochem Pharmacol, 2020; 174:​113783.
2. Roula D, Theiler A, Luschnig P, Böhm GJ, Tomazic PV, Marsche G, Heinemann A, Böhm EM: Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naïve allergic patients and allergen-challenged mice. Allergy, 2020; 75(2):​392–402.
3. Theiler A, Bärnthaler T, Platzer W, Richtig G, Peinhaupt M, Rittchen S, Kargl J, Ulven T, Marsh LM, Marsche G, Schuligoi R, Böhm EM, Heinemann A: Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival. J Allergy Clin Immunol, 2019; 144(3):​764–776.
4. Frei RB, Luschnig P, Parzmair GP, Peinhaupt M, Schranz S, Fauland A, Wheelock CE, Heinemann A, Böhm EM: Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice. Allergy, 2016; 71(7):​944–956.
5. Böhm EM, Parzmair GP, Radnai B, Frei RB, Böhm GJ, Hammer A, Schuligoi R, Lippe IT, Heinemann A: Phosphoinositide-dependent protein kinase 1 (PDK1) mediates potent inhibitory effects on eosinophils. Eur J Immunol, 2015; 45(5):​1548–1559.
6. Böhm EM, Radnai B, Jandl K, Stancic A, Parzmair GP, Högenauer C, Kump P, Wenzl H, Petritsch W, Pieber TR, Schuligoi R, Marsche G, Ferreirós N, Heinemann A, Schicho R: Opposing roles of prostaglandin D₂ receptors in ulcerative colitis. J Immunol, 2014; 193(2):​827–839.
7. Böhm EM, Dyer KD, Percopo CM, Heinemann A, Rosenberg HF: Chemotaxis of bone marrow derived eosinophils in vivo: a novel method to explore receptor-dependent trafficking in the mouse. Eur J Immunol, 2013; 43(8):​2217–2228.
8. Böhm EM, Schuligoi R, Konya V, Böhm GJ, Heinemann A: Inhibitory effect of prostaglandin I₂ on bone marrow kinetics of eosinophils in the guinea pig. J Leukoc Biol, 2011; 90(2):​285–291.
9. Böhm EM, Schratl P, Schuligoi R, Konya V, Böhm GJ, Lippe IT, Peskar BA, Heinemann A: Prostaglandin E₂ inhibits eosinophil trafficking through E-prostanoid 2 receptors. J Immunol, 2008; 181(10):​7273–7283.
10. Böhm E, Böhm GJ, Weiglhofer I, Sandig H, Shichijo M, McNamee A, Pease JE, Kollroser M, Peskar BA, Heinemann A: 11-Dehydro-thromboxane B₂, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J Biol Chem, 2004; 279(9):​7663–7670.

31.07.2020 RESPImmun · Doctoral Programme “Immune Modulation in Respiratory Diseases”